Publications
- Does DPP-IV Inhibition Offer New Avenues for Therapeutic Intervention in Malignant Disease?2022 | First Faculty of Medicine
- Sporadic Pancreatic Cancer: Glucose Homeostasis and Pancreatogenic Type 3 Diabetes2018 | First Faculty of Medicine, Third Faculty of Medicine
- Early detection of sporadic pancreatic cancer: time for change2017 | First Faculty of Medicine, Third Faculty of Medicine
- Lower plasma levels of glucose-dependent insulinotropic peptide (GIP) and pancreatic polypeptide (PP) in patients with ductal adenocarcinoma of the pancreas and their relation to the presence of impaired glucoregulation and weight loss2017 | First Faculty of Medicine
- Early detection of sporadic pancreatic cancer +12016 | First Faculty of Medicine, Third Faculty of Medicine
- Annual monitoring of side effects of administering sitagliptin in patients with type 2 diabetes mellitus2016 | First Faculty of Medicine, Third Faculty of Medicine
- The effect of dipeptidyl peptidase-IV inhibition on circulating T cell subpopulations in patients with type 2 diabetes mellitus2016 | First Faculty of Medicine, Third Faculty of Medicine
- Early detection of pancreatic cancer: Impact of high-resolution imaging methods and biomarkers2016 | First Faculty of Medicine, Third Faculty of Medicine
- Early pancreatic carcinogenesis - risk factors, early symptoms, and the impact of antidiabetic drugs2016 | First Faculty of Medicine
- Increased tissue and circulating levels of dipeptidyl peptidase-IV enzymatic activity in patients with pancreatic ductal adenocarcinoma2016 | First Faculty of Medicine
Loading network view...